Haleon (HLN) Recalls Gas-X Extra Strength Softgels Over Potential Safety Risk

Haleon plc (HLN) announced a voluntary recall of certain Gas-X Extra Strength softgels on June 5, 2026, citing a potential safety issue that could jeopardize consumer health. The recall targets specific lot numbers distributed across the U.S. The company urged consumers to immediately stop using the affected product and check packaging for recalled lot identifiers. No associated adverse events had been reported at the time of the announcement. Haleon stated it is coordinating with retailers and wholesalers to remove the impacted stock from store shelves. Gas-X is a widely used over-the-counter simethicone-based anti-gas treatment. The recall marks a reputational setback for Haleon’s consumer healthcare portfolio. Shares of the London-listed company have traded flat in early morning action.